Terms: = Leukemia AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Clinical Outcome
39 results:
1. Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML.
Lo Presti V; Meringa A; Dunnebach E; van Velzen A; Moreira AV; Stam RW; Kotecha RS; Krippner-Heidenreich A; Heidenreich OT; Plantinga M; Cornel A; Sebestyen Z; Kuball J; van Til NP; Nierkens S
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38580329
[TBL] [Abstract] [Full Text] [Related]
2. Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG).
Ozga M; Nicolet D; Mrózek K; Yilmaz AS; Kohlschmidt J; Larkin KT; Blachly JS; Oakes CC; Buss J; Walker CJ; Orwick S; Jurinovic V; Rothenberg-Thurley M; Dufour A; Schneider S; Sauerland MC; Görlich D; Krug U; Berdel WE; Woermann BJ; Hiddemann W; Braess J; Subklewe M; Spiekermann K; Carroll AJ; Blum WG; Powell BL; Kolitz JE; Moore JO; Mayer RJ; Larson RA; Uy GL; Stock W; Metzeler KH; Grimes HL; Byrd JC; Salomonis N; Herold T; Mims AS; Eisfeld AK
Leukemia; 2024 Jan; 38(1):45-57. PubMed ID: 38017103
[TBL] [Abstract] [Full Text] [Related]
3. [Prognostic factors of autologous hematopoietic stem cell transplantation in intermediate-risk acute myeloid leukemia patients with minimal residual disease negativity].
Lian JY; Ye PP; Cao JJ; Chen D; Wang TT; Si T; Yuan JJ; Lu Y
Zhonghua Nei Ke Za Zhi; 2022 Jun; 61(6):673-677. PubMed ID: 35673748
[TBL] [Abstract] [Full Text] [Related]
4. Overexpression of Prohibitin 2 Protein is Associated with Adverse Prognosis in Cytogenetically Normal Acute Myeloid leukemia.
Lee YE; Lim HJ; Park JH; Kim HR; Kang MG; Cho YK; Shin JH; Shin MG
Ann Lab Med; 2022 Sep; 42(5):585-589. PubMed ID: 35470276
[TBL] [Abstract] [Full Text] [Related]
5. Wilms' tumor 1 peptide-loaded dendritic cell vaccination in patients with relapsed or refractory acute leukemia.
Ogasawara M; Miyashita M; Yamagishi Y; Ota S
Ther Apher Dial; 2022 Jun; 26(3):537-547. PubMed ID: 35249263
[TBL] [Abstract] [Full Text] [Related]
6. Genetic features and efficacy of decitabine-based chemotherapy in elderly patients with acute myeloid leukemia.
Wang B; Guan W; Lv N; Li T; Yu F; Huang Y; Wang Y; Li L; Yu L
Hematology; 2021 Dec; 26(1):371-379. PubMed ID: 33971800
[TBL] [Abstract] [Full Text] [Related]
7. Association between the Wilms tumor-1 rs16754 polymorphism and acute myeloid leukemia: A MOOSE-compliant meta-analysis.
Yu X; Zhang Y; Liu S; Mu Y; Shang F; Zhang N
Medicine (Baltimore); 2020 Jul; 99(27):e20713. PubMed ID: 32629644
[TBL] [Abstract] [Full Text] [Related]
8. High WBP5 expression correlates with elevation of HOX genes levels and is associated with inferior survival in patients with acute myeloid leukaemia.
Ward C; Cauchy P; Garcia P; Frampton J; Esteban MA; Volpe G
Sci Rep; 2020 Feb; 10(1):3505. PubMed ID: 32103106
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic significance of The Wilms' Tumor-1 (wt1) rs16754 polymorphism in acute myeloid leukemia.
Petiti J; Rosso V; Lo Iacono M; Calabrese C; Signorino E; Gaidano V; Berger M; Saglio G; Cilloni D
Leuk Res; 2018 Apr; 67():6-11. PubMed ID: 29407184
[TBL] [Abstract] [Full Text] [Related]
10. [Donor chimerism and minimal residual disease monitoring in leukemia patients after allo-HSCT].
Bogdanov KV; Motorin DV; Nikulina TS; Pisotskaya OS; Babenetskaya DV; Mirolyubova YV; Volkova OY; Zaritskiy AY
Biomed Khim; 2017 Nov; 63(6):570-581. PubMed ID: 29251621
[TBL] [Abstract] [Full Text] [Related]
11. clinical outcome of Autologous Hematopoietic Cell Transplantation in Adult Patients with Acute Myeloid leukemia: Who May Benefit from Autologous Hematopoietic Cell Transplantation?
Yoon JH; Kim HJ; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
Biol Blood Marrow Transplant; 2017 Apr; 23(4):588-597. PubMed ID: 28089879
[TBL] [Abstract] [Full Text] [Related]
12. clinical significance of galectin-3 in patients with adult acute myeloid leukemia: a retrospective cohort study with long-term follow-up and formulation of risk scoring system.
Gao N; Yu WZ; Guo NJ; Wang XX; Sun JR
Leuk Lymphoma; 2017 Jun; 58(6):1394-1402. PubMed ID: 27736291
[TBL] [Abstract] [Full Text] [Related]
13. Prevalence and Prognostic Impact of Wilms' Tumor 1 (wt1) Gene, Including SNP rs16754 in Cytogenetically Normal Acute Myeloblastic leukemia (CN-AML): An Iranian Experience.
Toogeh G; Ramzi M; Faranoush M; Amirizadeh N; Haghpanah S; Moghadam M; Cohan N
Clin Lymphoma Myeloma Leuk; 2016 Mar; 16(3):e21-6. PubMed ID: 26725263
[TBL] [Abstract] [Full Text] [Related]
14. Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia.
Junghanns AS; Wittig S; Woehlecke C; Lehmann T; Arndt C; Gruhn B
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2221-8. PubMed ID: 26224397
[TBL] [Abstract] [Full Text] [Related]
15. Wilms' tumor gene 1 transcript levels in leukapheresis of peripheral blood hematopoietic cells predict relapse risk in patients autografted for acute myeloid leukemia.
Messina C; Candoni A; Carrabba MG; Tresoldi C; Sala E; Tassara M; Crippa A; Peccatori J; Assanelli A; Gattillo S; Bellio L; Fanin R; Ciceri F; Bernardi M
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1586-91. PubMed ID: 24954546
[TBL] [Abstract] [Full Text] [Related]
16. clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: results of the ALFA-0701 trial.
Renneville A; Abdelali RB; Chevret S; Nibourel O; Cheok M; Pautas C; Duléry R; Boyer T; Cayuela JM; Hayette S; Raffoux E; Farhat H; Boissel N; Terre C; Dombret H; Castaigne S; Preudhomme C
Oncotarget; 2014 Feb; 5(4):916-32. PubMed ID: 24659740
[TBL] [Abstract] [Full Text] [Related]
17. wt1 overexpression affecting clinical outcome in non-hodgkin lymphomas and adult acute lymphoblastic leukemia.
Ujj Z; Buglyó G; Udvardy M; Vargha G; Biró S; Rejtő L
Pathol Oncol Res; 2014 Jul; 20(3):565-70. PubMed ID: 24374862
[TBL] [Abstract] [Full Text] [Related]
18. Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia.
Hou HA; Lin CC; Chou WC; Liu CY; Chen CY; Tang JL; Lai YJ; Tseng MH; Huang CF; Chiang YC; Lee FY; Kuo YY; Lee MC; Liu MC; Liu CW; Lin LI; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
Leukemia; 2014 Jan; 28(1):50-8. PubMed ID: 23929217
[TBL] [Abstract] [Full Text] [Related]
19. leukemia associated mutant Wilms' tumor gene 1 protein promotes expansion of human hematopoietic progenitor cells.
Vidovic K; Ullmark T; Rosberg B; Lennartsson A; Olofsson T; Nilsson B; Gullberg U
Leuk Res; 2013 Oct; 37(10):1341-9. PubMed ID: 23871158
[TBL] [Abstract] [Full Text] [Related]
20. Combinatorial molecular marker assays of wt1, survivin, and TERT at initial diagnosis of adult acute myeloid leukemia.
Kim HJ; Choi EJ; Sohn HJ; Park SH; Min WS; Kim TG
Eur J Haematol; 2013 Nov; 91(5):411-22. PubMed ID: 23826993
[TBL] [Abstract] [Full Text] [Related]
[Next]